Hyperparathyroidism as a cause of recurrent acute pancreatitis – A case report

  • Snežana Tešic Rajković Clinic for Gastroenterology and Hepatology,Clinical Center Niš, Niš, Serbia
  • Biljana Radovanović Dinić Clinic for Gastroenterology and Hepatology,Clinical Center Niš, Niš, Serbia;Faculty of Medicine, University of Niš, Niš, Serbia
  • Branka Mitić Faculty of Medicine, University of Niš, Niš, Serbia; Institute of Nephrology and Hemodialysis, Clinical Center Niš, Niš, Serbia
  • Violeta Dinić Radović Clinic for Gastroenterology and Hepatology,Clinical Center Niš, Niš, Serbia
  • Maja Jovanović Faculty of Medicine, University of Niš, Niš, Serbia; Clinic for Infectious Diseases, Clinical Center Niš, Niš, Serbia
Keywords: pancreatitis, hyperparathyroidism, comorbidity, diagnosis, differential, kidney failure, chronic,

Abstract


Introduction. One of the more uncommon etiological factors responsible for the development of acute pancreatitis (AP) is hypercalcemia. Hyperparathyroidism (HPT), as a cause of hypercalcemia, is responsible for 1.5–13% of AP according to a number of studies. A mechanism of the development of AP in hyperparathyroidism is still unclear. Case report. We presented a 47-year-old female patient, who had five episodes of AP in total before the etiological factors were finally determined. The patient had certain comorbidities which were considered to be potential causes of AP. She had chronic renal insufficiency (she was on a regular hemodialysis program), systemic lupus erythematosus and mioma uteri. She used to regularly take an antiepileptic drug (combination of sodium valproate and valproic acid). During the fifth episode of AP, the serum calcium level was for the first time elevated to twice the normal value. Level of parathyroid hormone was several times higher. A static scintigraphy found hyperplasia or hyperfunctional adenoma of the right inferior and superior parathyroid glands. Abdominal multislice computed tomography (MSCT) scan verified the enlargement of the entire pancreas, as well as the presence of heterogeneous structures with diffuse amorphous calcifications. The lytic lesions in the pelvic bones could be seen in both sides. Parathyroidectomy was being postponed by an endocrine surgeon because of the poor overall condition of the patient. In the next period the patient had five more episodes of AP. The condition was significantly contributed by increasingly more frequent and longer episodes of metrorrhagia. Despite all therapeutic measures that were taken, systemic inflammatory response syndrome (SIRS) developed, and fatal outcome occurred. Conclusion. In case of recurrent pancreatitis, hyperparathyroidism is to be considered even if a significant elevation of serum calcium is not present. This is especially the case for patients with chronic renal insufficiency or impaired vitamin D metabolism, who have a higher risk of secondary hyperthyroidism.

References

Manguilar LA, Cruz SR, González VB, Vargas OG, Mercado AM, Ferreira HA, et al. Pancreatitis aguda en hiperparatiroidismo primario. Rev Endocrinol Nutr 2013; 21(3): 132−7.

Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet 2008; 371(9607): 143−52.

Bai HX, Giefer M, Patel M, Orabi AI, Husain SZ. The association of primary hyperparathyroidism with pancreatitis. J Clin Gastroenterol 2012; 46(8): 656−61.

Khoo TK, Vege SS, Abu-Lebdeh HS, Ryu E, Nadeem S,Wermers RA. Acute pancreatitis in primary hyperparathyroidism: a population-based study. J Clin Endocrinol Metab 2009; 94(6): 2115-18.

Carnaille B, Oudar C, Pattou F, Combemale F, Rocha J, Proye C. Pancreatitis and primary hyperparathyroidism: forty cases. Aust N Z J Surg. 1998; 68(2): 117−9.

Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006; 101(10): 2379−400.

Koppelberg T, Bartsch D, Printz H, Hasse C, Rothmund M. Pancrea-titis in primary hyperparathyroidism (pHPT) is a complication of advanced pHPT. Dtsch Med Wochenschr 1994; 119(20): 719−24. (German)

Ward JB, Petersen OH, Jenkins SA, Sutton R. Is an elevated con-centration of acinar cytosolic free ionised calcium the trigger for acute pancreatitis? Lancet 1995; 346(8981): 1016−9.

Mithöfer K, Fernández-del Castillo C, Frick TW, Lewandrowski KB, Rattner DW, et al. Acute hypercalcemia causes acute pancreatitis and ectopic trypsinogen activation in the rat. Gastroenterology 1995; 109(1): 239−46.

Jacob JJ, John M, Thomas N, Chacko A, Cherian R, Selvan B, et al. Does hyperparathyroidism cause pancreatitis. A south Indian experience and a review of published work? ANZ J Surg 2006; 76(8): 740–44.

Felderbauer P, Karakas E, Fendrich V, Bulut K, Horn T, Lebert R, et al. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene. Am J Gastroenterol 2008; 103(2): 368−74.

Shah AU, Sarwar A, Orabi AI, Gautam S, Grant WM, Park AJ, et al. Protease activation during in vivo pancreatitis is depen-dent upon calcineurin activation. Am J Physiol Gastrointest Liver Physiol 2009; 297(5): 967−73.

Felderbauer P, Klein W, Bulut K, Ansorge N, Dekomien G, Werner I, et al. Mutations in the calcium-sensing receptor: a new genetic risk factor for chronic pancreatitis? Scand J Gastroenterol 2006; 41(3): 343−8.

Chowdhury SD, Kurien RT, Pal S, Jeyaraj V, Joseph AJ, Dutta AK, et al. Acute pancreatitis and hyperparathyroidism: a case series. Indian J Gastroenterol 2014; 33(2): 175−7.

Ranson JH. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982; 77(9): 633−8.

Braun C, Duffau P, Mahon FX, Rosier E, Leguay T, Etienne G, et al. Acute pancreatitis due to hypercalcemia revealing adult T-cell leukemia. Rev Med Interne 2007; 28(2): 116−9. (French)

Kanno K, Hikichi T, Saito K, Watanabe K, Takagi T, Shibukawa G, et al. A case of esophageal small cell carcinoma associated with hypercalcemia causing severe acute pancreatitis. Fukushima J Med Sci 2007; 53(1): 51−60.

Abdullah M. Pancreatitis in primary hyperparathyroidism. Case report. Med J Malaysia 2003; 58(4): 600−3.

Cannata-Andia JB, Carrera F. The pathophysiology of secondary hyperparathyroidism and the consequences of uncontrolled mineral metabolism in chronic kidney disease: the role of COSMOS. Nephrol Dial Transplant 2008; 1(Suppl 1): 29−35.

Published
2017/03/13
Section
Case report